FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

fosinopril sodium and hydrochlorothiazide tablet

eon labs, inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8) - fosinopril sodium 10 mg

CHLORZOXAZONE tablet মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

chlorzoxazone tablet

cameron pharmaceuticals - chlorzoxazone (unii: h0de420u8g) (chlorzoxazone - unii:h0de420u8g) - chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of this drug has not been clearly identified, but may be related to its sedative properties. chlorzoxazone does not directly relax tense skeletal muscles in man. chlorzoxazone is contraindicated in patients with known intolerance to the drug.

OMISIRGE- omidubicel-onlv kit মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

omisirge- omidubicel-onlv kit

gamida cell inc. - omidubicel (unii: et4jc4s66e) (omidubicel - unii:et4jc4s66e) - omisirge is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy derived from cord blood indicated for use in adults and pediatric patients 12 years and older with hematologic malignancies who are planned for umbilical cord blood transplantation following myeloablative conditioning to reduce the time to neutrophil recovery and the incidence of infection. omisirge is contraindicated in patients with known hypersensitivity to dimethyl sulfoxide (dmso), dextran 40, gentamicin, human serum albumin, or bovine products. risk summary there are no available data with omisirge use in pregnant women. no animal reproductive and developmental toxicity studies have been conducted with omisirge to assess whether it can cause fetal harm when administered to a pregnant woman. omisirge should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. in the united states (u.s.) general population, the estimated background risk of major birth defects and miscarriage in

DEXTRAN 70 আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

dextran 70

baxter healthcare limited - dextran 70 glucose - solution for infusion - 6/5 %w/v

DEXTRAN 6% IN 5% DEXTROSE INJECTION SOLUTION কানাডা - ইংরেজি - Health Canada

dextran 6% in 5% dextrose injection solution

hospira healthcare ulc - dextran; dextrose - solution - 60mg; 50mg - dextran 60mg; dextrose 50mg - replacement preparations

DEXTRAN 6% IN 0.9% SODIUM CHLORIDE INJECTION SOLUTION কানাডা - ইংরেজি - Health Canada

dextran 6% in 0.9% sodium chloride injection solution

hospira healthcare ulc - dextran; sodium chloride - solution - 60mg; 9mg - dextran 60mg; sodium chloride 9mg - replacement preparations

6% Dextran 70 in 5% Glucose 500mL injection FKB5063G অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

6% dextran 70 in 5% glucose 500ml injection fkb5063g

baxter healthcare pty ltd - glucose monohydrate, quantity: 50 g/l; dextran 70, quantity: 60 g/l - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)